Yes, AN2 Therapeutics, Inc. is a publicly traded company. It is listed on the Nasdaq Stock Market under the ticker symbol ANTX. The biotechnology enterprise completed its initial public offering, allowing public market investors, institutional asset managers, and retail traders to buy and sell common shares through standard brokerage accounts.